Conversion calendar in hand: management narrates the coming year as dated deliveries of business already secured
The model's full reasoning — Q3 2022 call → NOThe question asks whether management lays out a timetable of specific conversions—identified pieces of business already secured or in motion, each attached to a time frame—so the forward story reads as a schedule of things turning on. Let me review the transcript for such specifics. Key forward-looking items mentioned: 1. CMS Final Rule for 2023 - facility reimbursement increases ~26% to $17,109 and 33% to $21,898. This is a reimbursement tailwind, not a secured conversion. It's a policy change, not a specific business item already won. 2. iFuse-TORQ - record revenue, exceeding expectations, but no specific timetable for future contributions. 3. iFuse-Bedrock Granite - strong surgeon interest, but they note "near-term delays in adequate availability of implants" and "both of these factors limited our ability to fully capitalize on the demand momentum in September and into the first half of the fourth quarter." This is about managing supply chain, not a secured schedule. 4. SAFFRON study - enrolled first of 120 patients, results expected late 2024. That's a clinical trial, not a revenue conversion. 5. Neville Lorimer appointment - international leadership, but no specific timetable. 6. Guidance for 2022 - $104-105M, implying Q4 growth 17-21% worldwide. This is guidance, not a schedule of secured conversions. The forward discussion focuses on: - Demand strength and acceleration - Surgeon adoption rates (27% growth in active surgeon base) - Reimbursement tailwinds - New product momentum (Granite, TORQ) - International challenges (Germany, UK underperformance) Management does NOT identify specific secured business items with timetables. The Granite supply chain issues are being worked through, but that's about resolving delays, not a schedule of conversions. The CMS reimbursement is a tailwind but not a secured conversion with a specific contribution schedule. The forward story rests on demand strength, market conditions, product momentum, and general optimism—not a dated schedule of already-secured items. Answer: NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
CPK · Q3 2017 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured business and approximate time frames.
SOL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.
FLL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.